Resilience

Resilience operates a network of high-tech manufacturing facilities providing biologics development and manufacturing, cell therapy manufacturing, aseptic drug product manufacturing, and device assembly services with quality-focused processes.

The company delivers more than 100 million vials and pre-filled syringes annually, maintains 100% pass rate for third-party and EU Annex 1 assessments, and recently secured $825 million in long-term financing.